Half of GLP-1 users ditch their injections - and some are turning to other weight-loss methods instead
MarketWatch • • health
Key Points:
- Millions of Americans have used GLP-1 weight-loss drugs, but some discontinue due to side effects, high costs, or lack of effectiveness.
- Health insurance changes at the start of the year and reduced employer coverage are making access to these expensive medications more difficult.
- Approximately half of patients who stop taking GLP-1 drugs, such as Eli Lilly’s Zepbound or Novo Nordisk’s Wegovy, regain all the weight they initially lost within two years.
